ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2685 • 2016 ACR/ARHP Annual Meeting

    Ultrasound of the Major Salivary Glands Is a Reliable Imaging Technique for Diagnosing Patients Clinically Suspected with SjöGren’s Syndrome

    Konstantina Delli1, Suzanne Arends2, Pieter U. Dijkstra3, Jolien F. van Nimwegen2, Alja J Stel2, Hendrika Bootsma4, Arjan Vissink1 and Fred K.L. Spijkervet5, 1Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Department of Rehabilitation, Center for Rehabilitation, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands, 5Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: In the classification criteria of Sjögren’s syndrome (SS), involvement of the salivary glands is currently assessed by sialography, scintigraphy, sialometry and histopathology. Recent discussions…
  • Abstract Number: 2686 • 2016 ACR/ARHP Annual Meeting

    Objective Improvement in Fatigue Scores for Primary Sjögren’s Patients Receiving a Tailored Multidisciplinary Fatigue Intervention in a Generic Fatigue Clinic

    Katie Hackett1,2, Robert Forder3, Dennis W Lendrem4, Ben Hargreaves5, Victoria Strassheim1,3, Zoe Gotts3, Vincent Deary1,6, Wan-Fai Ng7,8 and Julia Newton1,3, 1CRESTA Fatigue Clinic, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom, 2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 3Newcastle University, Newcastle upon Tyne, United Kingdom, 4Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 5Musculoskeletal Directorate, Newcastle upon Tyne NHS Foundation Trust, Newcastle, United Kingdom, 6School of Health Psychology, Northumbia University, Newcastle upon Tyne, United Kingdom, 7Musculoskeletal Research Group Institute of Cellular Medicine, Newcastle University, Newcastle University, Newcastle, England, 8Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Primary Sjögren’s syndrome (PSS) is an autoimmune disease which targets secretary glands resulting in dry eyes and mouth. Approximately 70% of PSS patients experience…
  • Abstract Number: 2687 • 2016 ACR/ARHP Annual Meeting

    Prevalence of Abortions and Fetal Atrioventricular Block in Patients with Positive ANTI-RO and ANTI-La Antibodies

    Isabel Martinez Cordellat1, Francisco Miguel Ortiz-Sanjuán1, Jose Ivorra Cortes1, Luis Gonzalez Puig1, Inmaculada Chalmeta Verdejo1, Irene Calabuig Sais2, Elena Grau Garcia1,3, Carlos Feced Olmos1, Eztizen Labrador Sanchez1, Karla Arevalo Ruales1, Rosa Negueroles Albuixech1, Jorge Fragio Gil1, Jose Luis Valero Sanz1, Cristina Alcañiz Escandell1,3, Carmen Najera Herranz1, Gema Poveda Marin1,3 and Jose Andres Roman Ivorra1,2,3, 1Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain, 2Universidad Católica de Valencia, Valencia, Spain, 3IIS La Fe, Valencia, Spain

    Background/Purpose:   anti-SSA/Ro and/or anti-SSB/La antibodies and to evaluate the prevalence of abortions and neonatal mortality.   We included 162 patients with positive anti-SSA/Ro and/or…
  • Abstract Number: 2688 • 2016 ACR/ARHP Annual Meeting

    Characteristics, Treatment and Outcome of Joint Involvement with Synovitis in Primary SjöGren’s Syndrome: French Multicentric Retrospective Case-Control Study

    Adrien Mirouse1, raphaèle seror2, Xavier Mariette3, Maxime Dougados4, Anne-Laure Fauchais5, Alban Deroux6, Nathalie Costedoat-Chalumeau7, Jeremie Sellam8, Jean-Benoit Arlet9, Christian Lavigne10, Dominique Fischer-Dumont11, Arsène Mékinian12 and Olivier Fain12, 1Service de médecine interne, Hôpital Saint-Antoine, Paris, France, 2INSERM U1184, Paris Sud University, Le Kremlin Bicetre, France, 3INSERM U1184, Université Paris-Sud, Paris, France, Le Kremlin Bicetre, France, 4Paris Descartes University, Paris, France, 5Department of Internal Medicine, CHU de Limoges, Limoges, France, 6Internal Medicine, CHU Grenoble, Grenoble, France, 7Internal Medicine, Cochin University Hospital, Paris, France, 8Rheumatology, Saint-Antoine Hospital, Paris, France, 9Service de médecine interne, Hopital Européen Georges Pompidou, Paris, France, 10CHU Angers, department of Internal Medicine, Angers, France, 11Service de rhumatologie, Hôpital Avicenne, Bobigny, France, 12Service de médecine interne. Hôpital Saint-Antoine., Paris, France

    Background/Purpose: primary Sjogren’s syndrome (pSS) articular manifestations include often tender joints and more rarely synovitis. The main objective of this study was to describe characteristics,…
  • Abstract Number: 2689 • 2016 ACR/ARHP Annual Meeting

    Comparison of the 2016 ACR/EULAR and the 2002 AECG Classification Criteria in a Cohort of Patients with Suspected Primary SjöGren’s Syndrome

    Divi Cornec1, Maëlle Le Goff2, Sandrine Jousse-Joulin3, Dewi Guellec4, Sebastian Costa5, Thierry Marhadour6, Jacques-Olivier Pers7, Alain Saraux8 and Valerie Devauchelle-Pensec9, 1Department of rheumatology, Brest Occidentale University, Brest, France, 2CHRU Brest, Brest, France, 3Rheumatology, CHu La cavle Blanche, Brest, France, 4Rheumatology Department, CHU de la Cavale Blanche, Brest, France, 5anatomopathological department, Brest university hospital, Brest, France, 6Rheumatology, CHU La Cavale Blanche, Brest, France, 7INSERM ERI29, EA2216, Université de Brest, Labex IGO, CHRU Morvan, Brest, France, 8Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 9Rheumatology Department, Brest University Hospital, Brest, France

    Background/Purpose: New consensual classification criteria for primary Sjögren’s syndrome (pSS) have been recently developed, validated, and submitted to ACR and EULAR committees. They differ substantially…
  • Abstract Number: 2690 • 2016 ACR/ARHP Annual Meeting

    Detection of Dorsal Root Ganglionitis with Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with SjöGren’s Syndrome

    Takeshi Yoshida1, Takeshi Sueyoshi2, Shugo Suwazono3 and Mitsuyo Kinjo4,5, 1Internal Medicine, Okinawa Chubu Hospital, Uruma, Japan, 2Radiology, Minei Daiichi Hospital, Urasoe, Japan, 3Brain-Nerve-Muscle Research Center, National Hospital Organization Okinawa Hospital, Uruma, Japan, 4Rheumatology, Okinawa Chubu Hospital, Uruma, Japan, 5Internal Medicine, Okinawa Chubu Hospital, Uruma City Okinawa, Japan

    Background/Purpose: Sensory ataxic neuropathy (SAN) is one of the neurologic complications in Sjögrenfs syndrome (SS). The underlying pathology was lymphocytic infiltration to the dorsal root…
  • Abstract Number: 2691 • 2016 ACR/ARHP Annual Meeting

    Clinical, Radiological and Functional Characteristics of Clinically Significant Pulmonary Involvement in Primary SjöGren’s Syndrome

    Christos F Kampolis1, Sofia Fragkioudaki1, Alexandra Zormpala2, Anastasia Samakovli3 and Haralampos M. Moutsopoulos1, 1Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Radiology, "Laiko" General Hospital, Athens, Greece, 3Respiratory Department, “Evgenidion Clinic Agia Trias”, Athens, Greece

    Background/Purpose: Prevalence of symptomatic pulmonary disease in primary Sjögren’s Syndrome (pSS) ranges between 9% and 27%. Xerotrachea, small airway disease and interstitial lung disease (ILD)…
  • Abstract Number: 2692 • 2016 ACR/ARHP Annual Meeting

    Pulmonary Involvement, As Part of the Essdai, in Primary Sjogren’s Syndrome

    Anne Heus1, Suzanne Arends1, Jolien F. van Nimwegen1, Alja J. Stel1, George D. Nossent2 and Hendrika Bootsma3, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Pulmonary Medicine and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose:  In previous studies in primary Sjögren’s syndrome (pSS), the prevalence of pulmonary involvement varied greatly depending on differences in inclusion criteria, imaging modalities and…
  • Abstract Number: 2693 • 2016 ACR/ARHP Annual Meeting

    Evolution of Disease Activity over a 5-Year Period in the  395 Patients with Primary SjöGren’s Syndrome of the Assess Prospective Cohort

    Jacques-Eric Gottenberg1, Raphaele Seror2, Alain Saraux3, Valerie Devauchelle4, Emmanuelle Dernis Labous5, Philippe Dieudé6, Jean-Jacques Dubost7, Anne Laure Fauchais8, Vincent Goeb9, Claire Larroche10, Véronique Le-Guern11, Eric Hachulla12, Pierre Yves Hatron13, Jacques Morel14, Aleth Perdriger15, Stephanie Rist Bouillon16, Damien Sène17, Olivier Vittecoq18, Jean Sibilia19, Philippe Ravaud20 and Xavier Mariette21, 1Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 2Department of Rheumatology, Assistance Publique–Hopitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin Bicêtre, France, 3Rheumatology, Brest University Hospital, Brest, France, 4Service de Rhumatologie, Department of Rheumatology, Brest University Hospital, Brest, France, Brest, France, 5Le Mans Hospital, Le Mans, France, 6Rheumatology, Hôpital Bichat, Paris, France, 7Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, 8Rheumatology, Limoges, France, 9Rhumatologie, CHU Amiens, Amiens, France, 10Internal Medicine, Paris, France, 11service de médecine interne, Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 12Internal Medicine, Lille University Hospital, Lille, France, 13Internal Medicine, Lille, France, 14Rheumatology, Department of Rheumatology, Montpellier University Hospital, Montpellier, France, 15C.H.R. Hôpital Sud, Rennes, France, 16Rhumatologie, Hopital La Source, La Source, France, 17Department of Internal Medicine, Pitié-Salpêtrière Hospital, Paris, France, 18Rheumatology, Rouen University Hospital &INSERM U905, Rouen, France, 19Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 20Epidemiologist, PARIS, France, 21Rheumatology, Rheumatology department, Bicetre Hospital, Paris-Sud University, Le Kremlin Bicetre, France

    Background/Purpose: Little is known about the natural history of primary Sjögren’s syndrome due to the limited number of prospective cohorts followed up in a yearly…
  • Abstract Number: 2694 • 2016 ACR/ARHP Annual Meeting

    Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis

    Linda Rehaume1, Nicholas Matigian1, Alicia Kang1, Olga Zbarskaya1, Kristine Kikly2, Nancy Lachner3, Joshua Daly3, Philip Hugenholtz3, Mark Morrison1, Kim-Anh Lê Cao4 and Ranjeny Thomas1, 1Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia, 2Biotechnology Discovery Research, Eli Lilly and Co, Indianapolis, IN, 3The University of Queensland, Australian Centre for Ecogenomics, Brisbane, Australia, 4Translational Research Instiute, The University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose: Identification of disease-associated or protective bacteria may elucidate new biomarkers or probiotic supplements for people suffering from spondyloarthritis (SpA), or for people at-risk of…
  • Abstract Number: 2695 • 2016 ACR/ARHP Annual Meeting

    Genetic Association of Ankylosing Spondylitis with TBX21 Influences T-Bet and Pro-Inflammatory Cytokine Expression in Humans and SKG Mice As a Model of Spondyloarthritis and Alters Host Microbiome and Response to Microbial Stimuli

    Max Lau1, Patricia Keith1, Madeline McCready1, Mary-Ellen Costello1, Linda Bradbury1, Kelly Holiis1, Ranjeny Thomas2, Gethin P. Thomas3, Matthew A. Brown1 and Tony J. Kenna1, 1Translational Research Institute, Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia, 2Translational Research Institute, The University of Queensland Diamantina Institute, Brisbane, Australia, 3Translational Reserch Institute, The University of Queensland Diamantina Institute, Brisbane, Australia

    Background/Purpose: TBX21 encodes the transcription factor T-bet and is genome-wide significant associated with ankylosing spondylitis (AS). T-bet is implicated in innate and adaptive immunity. However,…
  • Abstract Number: 2696 • 2016 ACR/ARHP Annual Meeting

    Identification of a Potential Commensal Immunologic Target in Enthesitis-Related Arthritis

    Matthew L. Stoll1, Lennard W. Duck2, Randy Q. Cron3 and Charles O. Elson4, 1University of Alabama at Birmingham, Birmingham, AL, 2Medicine, University of Alabama at Birmingham, Birmingham, AL, 3Pediatric Rheumatology, Children's Hospital of Alabama, Birmingham, AL, 4Dept of Medicine, University of Alabama at Birmingham, Birmingham, AL

    Identification of a Potential Commensal Immunologic Target in Enthesitis-related Arthritis Background/Purpose: Research in inflammatory bowel disease (IBD) has identified commensal organisms that stimulate humoral and…
  • Abstract Number: 2697 • 2016 ACR/ARHP Annual Meeting

    Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model

    Luiza Krause1, Quentin Jouhault2, Bilade Cherqaoui1, Aude Jobart-Malfait1, Ignacio Anegon3, Gilles Chiocchia4 and Maxime A. Breban5, 1INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 2Infection and inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 3U643, INSERM-UMR643- Nantes-CHU, Nantes, France, 4Infection and Inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 5Rheumatology, Ambroise Paré Hospital, and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

    Background/Purpose:  HLA-B27/hβ2m transgenic rats (B27 rats), a model of spondylarthritis (SpA) develop spontaneous colitis and arthritis. Recently, in vitro studies demonstrated that altered dendritic cells…
  • Abstract Number: 2698 • 2016 ACR/ARHP Annual Meeting

    Regulation of Inflammation By Interleukin-27 in a Rat Model of Spondyloarthritis (SpA)

    Quentin Jouhault1, Maxime A. Breban2, Luiza Krause3 and Gilles Chiocchia3, 1Infection and inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 2Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 3Infection and Inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France

    Background/Purpose:  SpA is a chronic inflammatory rheumatic disorder with osteo-articular and extra-articular manifestations. HLA-B27/human β2-microglobulin transgenic rats (B27 rat) spontaneously develop a phenotype closely resembling…
  • Abstract Number: 2699 • 2016 ACR/ARHP Annual Meeting

    Spa-Associated HLA-B*27 Subtypes Accumulate More in Endoplasmic Reticulum (ER) Compartment and in Association with β2-Microglobulin (β2m) Than Non-Associated HLA-B Alleles

    Nadège Jah1, Gilles Chiocchia2, Maxime A. Breban3 and Claudine Andre1, 1Infection and inflammation, INSERM UMR1173, Montigny-le-Bretonneux, France, 2Infection and Inflammation, INSERM-U1173, University of Versailles Saint-Quentin-en-Yvelines, France, Montigny-le-Bretonneux, France, 3Rheumatology, Ambroise Paré Hospital (AP-HP), Versailles Saint Quentin en Yvelines University, INSERM UMR1173, Boulogne-Billancourt, France

    Background/Purpose: Mechanisms underlying the striking association of SpA with the MHC class I molecule HLA-B27 remain poorly understood. SpA-like disease develops spontaneously in B*2705 transgenic…
  • « Previous Page
  • 1
  • …
  • 1594
  • 1595
  • 1596
  • 1597
  • 1598
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology